Back to Search Start Over

Phosphorylation of SOS1 on tyrosine 1196 promotes its RAC GEF activity and contributes to BCR-ABL leukemogenesis

Authors :
Asociación Española Contra el Cáncer
Ministry of Science, Research and Art Baden-Württemberg
European Commission
European Research Council
Josep Carreras Leukemia Foundation
Associazione Italiana per la Ricerca sul Cancro
Fondazione Cariplo
Association for International Cancer Research
Ministero dell'Istruzione, dell'Università e della Ricerca
Gerboth, S.
Frittoli, E.
Palamidessi, A.
Baltanás, Fernando C.
Salek, M.
Rappsilber, J.
Giuliani, C.
Troglio, F.
Rolland, Y.
Pruneri, G.
Kreutmair, S.
Pallavicini, I.
Zobel, M.
Cinquanta, M.
Minucci, S.
Gómez, Carmela
Illert, A.L.
Scita, G.
Asociación Española Contra el Cáncer
Ministry of Science, Research and Art Baden-Württemberg
European Commission
European Research Council
Josep Carreras Leukemia Foundation
Associazione Italiana per la Ricerca sul Cancro
Fondazione Cariplo
Association for International Cancer Research
Ministero dell'Istruzione, dell'Università e della Ricerca
Gerboth, S.
Frittoli, E.
Palamidessi, A.
Baltanás, Fernando C.
Salek, M.
Rappsilber, J.
Giuliani, C.
Troglio, F.
Rolland, Y.
Pruneri, G.
Kreutmair, S.
Pallavicini, I.
Zobel, M.
Cinquanta, M.
Minucci, S.
Gómez, Carmela
Illert, A.L.
Scita, G.
Publication Year :
2018

Abstract

Son of Sevenless 1 (SOS1) is a dual guanine nucleotide exchange factor (GEF) that activates the small GTPases RAC and RAS. Although the molecular mechanisms of RAS GEF catalysis have been unveiled, how SOS1 acquires RAC GEF activity and what is the physio-pathological relevance of this activity is much less understood. Here we show that SOS1 is tyrosine phosphorylated on Y1196 by ABL. Phosphorylation of Y1196 controls SOS1 inter-molecular interaction, is required to promote the exchange of nucleotides on RAC in vitro and for platelet-derived growth factor (PDGF) activation of RAC- and RAC-dependent actin remodeling and cell migration. SOS1 is also phosphorylated on Y1196 by BCR-ABL in chronic myelogenous leukemic cells. Importantly, in these cells, SOS1 is required for BCR-ABL-mediated activation of RAC, cell proliferation and transformation in vitro and in a xenograft mouse model. Finally, genetic removal of Sos1 in the bone marrow-derived cells (BMDCs) from Sos1 fl/fl mice and infected with BCR-ABL causes a significant delay in the onset of leukemogenesis once BMDCs are injected into recipient, lethally irradiated mice. Thus, SOS1 is required for full transformation and critically contribute to the leukemogenic potential of BCR-ABL.

Details

Database :
OAIster
Notes :
English
Publication Type :
Electronic Resource
Accession number :
edsoai.on1103439179
Document Type :
Electronic Resource